Strengths: The main strength of this study is the inclusion of recent studies showing a clear trend of improvement in survival and disease-free period in patients with low tumour residue after optimal cytoreductive surgery, without assuming an increase in toxicity.
← all excerpts
Should We Abandon Intraperitoneal Chemotherapy in the Treatment of Advanced Ovarian Cancer? A Meta-Analysis.
1
—
—